Private equity firm Revelstoke Capital Partners has officially closed its acquisition of Monte Nido & Affiliates, a prominent operator in the eating disorder treatment space, for an undisclosed sum. This deal marks a significant milestone in eating disorder treatment expansion, reflecting growing investment and increasing attention on behavioral health services nationwide. As eating disorders continue to impact millions of Americans, the partnership between Revelstoke and Monte Nido is poised to drive much-needed growth and innovation in specialized care.
Monte Nido’s Role in Eating Disorder Treatment Expansion
Since its founding in 1996, Monte Nido & Affiliates has emerged as a leader in eating disorder treatment expansion by building a network of five brands and operating 45 treatment facilities across 15 states. Based in Miami, Florida, Monte Nido primarily serves young women aged 14 to 28, a demographic significantly affected by eating disorders. The organization provides a comprehensive continuum of care, including inpatient, residential, partial hospitalization, and intensive outpatient programs, ensuring patients receive the right level of support throughout their recovery journey.
Monte Nido’s clinical approach combines evidence-based therapies with a multidisciplinary team model, which has been instrumental in expanding access to quality care. Their commitment to individualized treatment plans and family involvement further distinguishes them in the field, positioning the organization as a key driver of eating disorder treatment expansion across the country.
How Revelstoke is Driving Eating Disorder Treatment Growth
The infusion of capital and strategic resources from Revelstoke is expected to accelerate Monte Nido’s organic growth while facilitating additional acquisitions and the development of new treatment facilities. This dual approach is central to advancing eating disorder treatment expansion in regions where access to specialized care remains limited.
Candy Henderson, CEO of Monte Nido, expressed optimism about the new partnership, stating, “The financial and operational resources from this new partnership will be used to further support our rapid growth by facilitating acquisitions and the development of new facilities. We look forward to working together to deliver high quality eating disorder services to even more patients.” This vision underscores the critical role that investment and operational support play in scaling services to meet increasing demand.
The Growing Need for Eating Disorder Treatment Expansion
Eating disorders remain a significant public health concern in the United States, affecting approximately 5.48 million people annually, according to a recent Deloitte report. The disorders not only cause severe emotional and physical distress but also impose a staggering economic burden estimated at $64.7 billion per year. This figure includes direct healthcare costs, lost productivity, and other associated expenses.
These statistics highlight the urgent need for continued eating disorder treatment expansion to bridge gaps in care and improve outcomes for patients. As awareness grows and more people seek help, treatment providers must expand their capacity and develop innovative solutions to accommodate this surge.
Revelstoke’s Behavioral Health Strategy and Eating Disorder Treatment Expansion
Revelstoke Capital Partners has a strong history of investing in healthcare and behavioral health, managing approximately $4.8 billion in assets and completing 165 acquisitions since its founding in 2013. The firm’s growing behavioral health portfolio reflects a strategic commitment to supporting providers that address critical patient needs through high-quality care delivery.
Revelstoke’s recent acquisitions include Crossroads Treatment Centers, an addiction treatment provider recapitalized in partnership with Canada’s Caisse de dépôt et placement du Québec (CDPQ), and Family Care Center, an outpatient psychiatric service provider focused on military members and veterans. These investments complement the firm’s commitment to eating disorder treatment expansion, reinforcing its role as a catalyst for growth and innovation in behavioral health.
The Role of Mergers and Acquisitions in Eating Disorder Treatment Expansion
Monte Nido itself has leveraged mergers and acquisitions to extend its reach. In 2021, the company acquired Walden Behavioral Care, a Massachusetts-based organization specializing in eating disorders and psychiatric conditions. This acquisition broadened Monte Nido’s geographic footprint and enhanced its clinical offerings.
Such M&A activity is essential to eating disorder treatment growth, allowing providers to combine expertise, optimize resources, and accelerate the development of new programs. With Revelstoke’s backing, Monte Nido is well-positioned to continue this growth strategy, expanding access to care in underserved communities and adapting to evolving patient needs.
Digital Innovation Supports Eating Disorder Treatment Growth
Eating disorder treatment growth is also being propelled by advances in digital health. Virtual care models have gained traction, particularly during and after the COVID-19 pandemic, by reducing barriers such as geographic distance and stigma.
Companies like Equip, which specializes in virtual family-based treatment for eating disorders, raised $58 million in Series B funding this year, bringing their total funding to $75 million. Similarly, Arise, a digital eating disorder provider, secured $4 million in funding over the summer. These investments demonstrate growing confidence in technology-enabled treatment models that complement traditional facility-based care.
Digital-first approaches play a critical role in eating disorder treatment expansion by enabling providers to reach more patients efficiently, provide timely support, and offer flexible care options tailored to individual needs.
What Eating Disorder Treatment Expansion Means for Patients and Communities
The partnership between Revelstoke and Monte Nido represents a promising development in eating disorder treatment growth, aiming to improve access and quality of care for patients nationwide. With enhanced financial resources, operational expertise, and a clear growth strategy, Monte Nido is poised to develop new facilities, acquire complementary providers, and innovate its clinical programs.
For patients and families affected by eating disorders, this expansion means more opportunities to receive specialized, evidence-based care in welcoming environments. Communities across the U.S. stand to benefit from increased availability of these critical services as the mental health landscape evolves to meet rising demand.
